NEWS: Asthma drug brand blows out Shire Hall

Allen and Hanburys, the asthma products subsidiary of pharmaceuticals giant Glaxo Wellcome, has dropped Shire Hall from its lucrative Flixotide public relations account.

Allen and Hanburys, the asthma products subsidiary of pharmaceuticals

giant Glaxo Wellcome, has dropped Shire Hall from its lucrative

Flixotide public relations account.



An inhaled steroid available on prescription, Flixotide has been

promoted by Shire Hall since it was launched in the UK three years ago.

Working with Glaxo Wellcome’s in-house marketing department, the agency

attempted to position the drug as the market leader in an increasingly

competitive respiratory drugs market.



The total public relations spend allocated to the drug each year is

around pounds 200,000. Agency fees are thought to account for around

half that.



Glaxo Wellcome’s senior communications executive Anette Kjoller

confirmed that Allen and Hanburys had decided to terminate its

relationship with Shire Hall, although the agency would continue to work

on existing Flixotide projects for the next two to three months.



Kjoller declined to explain why Shire Hall was being dropped, but

referred to ‘personal issues within the account team’.



‘There was a misunderstanding of what they delivered and what we

expected,’ she said.



Allen and Hanburys is now scouring the PR market for a replacement and

is believed to have approached at least one other healthcare specialist.



On sale in 30 countries, Flixotide netted sales worth pounds 36 million

in the first half of 1995 and is one of Glaxo Wellcome’s biggest earners

worldwide.



Shire Hall continues to work for the company on several other public

relations projects, including its asthma marketing development

programme, the Lamictal epilepsy drug and its Beconase and Flixonase hay

fever products.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.